Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-02-28
2006-02-28
Nashed, Nashaat T. (Department: 1656)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C514S002600, C514S802000, C514S822000, C530S383000, C530S395000
Reexamination Certificate
active
07005502
ABSTRACT:
Described is a pharmaceutical preparation for treating blood coagulation disorders comprising an effective amount of vWf propeptide as well as a method for producing such a prepartion.
REFERENCES:
patent: 4160025 (1979-07-01), Eibl et al.
patent: 4395396 (1983-07-01), Eibl et al.
patent: 4640834 (1987-02-01), Eibl et al.
patent: 4814277 (1989-03-01), Eibl et al.
patent: 5198349 (1993-03-01), Kaufman
patent: 5408039 (1995-04-01), Burnouf-Radosevich et al.
patent: 5571784 (1996-11-01), Reers et al.
patent: 5610147 (1997-03-01), Seelich
patent: 5614405 (1997-03-01), Eibl et al.
patent: 5639730 (1997-06-01), Eibl et al.
patent: 5714370 (1998-02-01), Eibl et al.
patent: 5733885 (1998-03-01), Eibl et al.
patent: 350 726 (1979-06-01), None
patent: 368 883 (1982-11-01), None
patent: 398 079 (1994-09-01), None
patent: 404 359 (1998-11-01), None
patent: 404 554 (1998-12-01), None
patent: 1239583 (1988-07-01), None
patent: 2071567 (1992-12-01), None
patent: 0 131 740 (1985-01-01), None
patent: 0 159 311 (1985-10-01), None
patent: 0 247 998 (1987-12-01), None
patent: 0 519 901 (1992-12-01), None
patent: 0 131 740 (1994-09-01), None
patent: 0 637 451 (1995-02-01), None
patent: 07330797 (1995-12-01), None
patent: WO 94/13329 (1994-06-01), None
patent: WO 97/41206 (1997-11-01), None
Takagi et al. Inhibition of platelet-collagen interaction by propolypeptides of von Willebrand factor. (1989) J. Biol. Chem. vol. 264, No. 11, pp. 6017-6020.
Fujisawa et al. Monoclonal antibodies that inhibit binding of propolypeptides of von Willebrand factor to collagen. Localization of epitopes. (1991) Eur. J. Biochem. vol. 196, No. 3, pp. 673-677.
Turecek et al. Evidence for Extracellular Processing of Pro-von Willebrand Factor After Infusion in Animals iwth and Without Severe von Willebrand disease. (1999) Blood 94(5): 1637-1647.
Ruggeri et al. The Structure and Function of von Willebrand Factor. (1992) Thromb. Haemost. 67(6): 594-599.
Wise et al. The Propeptide of von Willebrand Factor Independently Mediates the Assembly of von Willebrand Multimers. (198 Cell 52: 229-236.
Fischer et al. Structural Analysis of recombinant von Willebrand Factor: identification of hetero- and homo-dimers (1994) FEBS Lett. 351: 345-348.
Mejan et al. Immunopurification of Human Factor VIII/vWF Complex from Plasma. (1988) Thromb. Haemost. 59(3): 364-371.
Official Action for A 917/97 dated Dec. 12, 1997. **Considered with Respect to Translation (Ref AK of Paper No.: 9) Oct. 30, 2001.
International Search Report for PCT/AT98/03090, dated Oct. 10. 1998.
Blann, A.D. et al., “von Willebrand Factor, Endothelial Cell Damage and Atherosclerosis”,Eur. J. Vasc. Surg.,vol. 8, 1994, pp 10-15.
Borchiellini, A. et al., “Quantitative Analysis of von Willebrand Factor Propeptide Release in vivo: Effect of Experimentation Endotoxemia and Administration of 1-Deamino-8-D-Arginine Vasopressin in Humans”,Blood, vol. 88, 1996, pp. 2951-2958.
Eikenboom, J.D.J. et al., “The Inheritance and Molecular Genetics of von Willebrand's Disease”,Haemophilia, , vol. 1, 1995, pp. 77-90.
Fischer B.E. et al., “Structural Analysis of Recombinant von Willebrand Factor; Identification of Hetero- and Homo-dimers”,FEBS Letters, vol. 351, 1994, pp. 345-348, Abstract # XP-002078562.
Fischer B.E. et al., “Structural Analysis of Recombinant von Willebrand Factor Produced at Industrial Scale Fermentation of Transformed CHO cells co-expressing Recombinant Furin”,FEBS Letters, vol. 375, 1995, pp. 259-262, Abstract # XP-002078561.
Isobe, T. et al., “Propolypeptide of von Willebrand Factor Is a Novel Ligand for Very Late Antigen-4 Integrin”,J. of Biol. Chem.,vol. 272, 1997, pp. 8447-8453, Abstract # XP-002078564.
Lankhof H. et al., “von Willebrand Factor Without the A2 Domain Is Resistant to Proteolysis”,Thromb. and Haemostasis, vol. 77, 1997, pp. 1008-1013.
Leyte A. et al., “The Pro-polypeptide of von Willebrand Factor is Required for the Formation of a Functional Factor VIII-Binding Site on Mature von Willebrand Factor”,Biochem., vol. 274, 1991, pp. 257-261, Abstract # XP-002078565.
Takagi, J. et al., “A Collagen-binding Glycoprotein From Bovine Platelets Is Identical to Propolypeptide of von Willebrand Factor”,J. of Biol. Chem.,vol. 264, 1989, pp. 10425-10430.
Takagi J. et al., “Inhibition of Platelet-Collagen Interaction by Propolypeptide of von Willebrand Factor”,J. Biol. Chem.,vo. 264, 1989, pp. 6017-6020, Abstract # XP-002078563.
Official Action for A917/97 dated Dec. 12, 1997, (translation).
Borchiellini, Alessandra, et al; Quantitative Analysis of von Willebrand Factor Propeptide Release In Vivo: Effect of Experimental Endotoxemia and Administration of I-Deamino-8-D-Arginine Vasopressin in Humans:Blood; Oct. 15, 1996; pp. 2951-2958, vol. 88, No. 8.
Lenting, Peter J., et al.; The Life Cycle of Coagulation Factor VIII in View of its Structure and Function;Blood; Dec. 1, 1998, pp. 3983-3996; vol. 92, No. 11.
Stedman's Medcal Dicitionary; 26thEdition; copyright 1995; p. 1300.
Turecek, Peter I., et al.; In vivo and in vitro processing of recombinant pro-von Willebrand factor;Histochem Cell Biol; 2002; 123-129; vol. 117.
Váradi, Katalin, et al.; Thrombin-mediated In Vitro Processing of Pro-von Willebrand Factor;Thromb Haemost.2001; pp. 1449-1458; vol. 86.
Wagner, Denisa D, et al.; Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells;Proc. Natl. Acad. Sci USA; Apr. 1987, pp. 1955-1959; vol. 84.
Beguin Suzette Lucette
Hemker Hendrik Coenraad
Schwarz Hans-Peter
Turecek Peter
Varadi Katalin
Baxter Aktiengesellschaft
Nashed Nashaat T.
Schnizer Holly
Townsend and Townsend / and Crew LLP
LandOfFree
Pharmaceutical preparation comprising vWF propeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical preparation comprising vWF propeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical preparation comprising vWF propeptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3648464